Współczesna Onkologia

Abstract

4/2013 vol. 17
Original paper

Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer

Contemp Oncol (Pozn) 2013; 17 (4): 350–355
Online publish date: 2013/10/07
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Aim of the study: To study high mobility group protein B1 (HMGB1) and nuclear transcription factor p65 (NF-κB p65) ex­­pression in non-small cell lung cancer and its significance.

Material and methods: 106 hospitalized patients with non-small cell lung cancer after thoracic surgery were enrolled; HMGB1 and p65 protein expression was detected by the immunohistochemical method. Semiquantitative expression of HMGB1 and NF-κB p65 was analyzed using Image Pro Plus (IPP) software and statistical analysis.

Results: The rate of HMGB1 positive expression in the non-small cell lung cancer protein B1 family was significantly higher than normal tissues (P < 0.05); p65 protein expression in the non-small cell lung carcinoma group was significantly higher than that of normal tissues (P < 0.05). HMGB1 and NF-κB p65 protein expression was significantly higher compared with the non-metastatic group (P < 0.01). HMGB1 and NF-κB p65 protein expression showed a positive correlation (P < 0.05).

Conclusions: HMGB1 and NF-κB p65 ex­pression may be related to non-small cell lung cancer metastasis.
Share
without publication fees